Nesivine (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa.

• Common cold: provides rapid reduction of nasal swelling, helping to clear blocked passages and improve breathing during viral upper respiratory infection.
• Sinusitis: decreases mucosal edema, facilitating sinus drainage and relieving pressure associated with acute or chronic sinus inflammation.
• Allergic rhinitis: alleviates congestion caused by allergic inflammation, improving airflow and reducing the sensation of a blocked nose.

• Oxymetazoline Hydrochloride acts as a selective alpha‑adrenergic receptor agonist on the smooth muscle of nasal mucosal blood vessels. Activation of these receptors induces vasoconstriction, which reduces blood flow, diminishes mucosal edema, and consequently opens the nasal airway, providing short‑term decongestion.

Oxymetazoline Hydrochloride is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects

• Nasal irritation or burning sensation
• Dryness of the nasal mucosa
• Sneezing or mild epistaxis
• Headache
• Transient taste disturbance
• Rebound congestion with prolonged use (>3 days)

Serious or Rare Side Effects

• Severe hypertension or hypertensive crisis
• Cardiac arrhythmias or palpitations
• Chest pain or angina
• Allergic reaction (rash, swelling, difficulty breathing)
• Nasal ulceration or necrosis
• Vision changes due to orbital involvement

When using Nesivine, consider the following safety measures.

• Duration of use: limit to three consecutive days to avoid rebound congestion.
• Age restrictions: not recommended for children under six years unless directed by a healthcare professional.
• Cardiovascular conditions: consult a physician if you have hypertension, heart disease, or arrhythmias.
• Pregnancy and breastfeeding: discuss potential risks with a qualified healthcare provider before use.
• Concomitant nasal products: avoid using other vasoconstrictive nasal sprays simultaneously.
• Store at room temperature: keep in the original container, protect from moisture and direct heat.

Oxymetazoline may interact with other sympathomimetic agents and cardiovascular drugs.

Major Interactions (Avoid)

• Oral decongestants (e.g., pseudoephedrine): additive systemic vasoconstriction may raise blood pressure.
• Sympathomimetic agents (e.g., phenylephrine): increased risk of hypertensive events.
• Monoamine oxidase inhibitors (MAOIs): potential for severe hypertension.

Moderate Interactions (Monitor Closely)

• Antihypertensive medications: nasal vasoconstriction may reduce their effectiveness.
• Beta‑blockers: may mask tachycardia caused by systemic absorption.
• Tricyclic antidepressants: possible additive cardiovascular stimulation.